Suppr超能文献

通过腹腔镜与开放手术对晚期卵巢癌进行间隔期完全大体切除后的总生存期:一项基于国家癌症数据库的分析

Overall Survival Following Interval Complete Gross Resection of Advanced Ovarian Cancer via Laparoscopy Versus Open Surgery: An Analysis of the National Cancer Database.

作者信息

Hayek Judy, An Anjile, Wolf Jennifer, Lamiman Kelly, Kim Michael, Knochenhauer Hope, Goncalves Nicole, Alagkiozidis Ioannis

机构信息

Department of Gynecologic Oncology, SUNY Downstate Health Sciences University, Brooklyn, NY 11203, USA.

Department of Obstetrics and Gynecology, Maimonides Medical Center, Brooklyn, NY 11219, USA.

出版信息

J Clin Med. 2025 Feb 11;14(4):1164. doi: 10.3390/jcm14041164.

Abstract

Advanced epithelial ovarian cancer (EOC) has traditionally been treated with primary debulking surgery; however, recent phase III trials have demonstrated similar survival outcomes for patients who were randomized to neoadjuvant chemotherapy followed by interval debulking (IDS) when compared to patients who underwent PDS. We sought to evaluate a cohort of patients with EOC diagnosed between 2010 and 2019 who underwent complete cytoreduction (R0-no gross residual disease) during IDS. We compared the outcomes after R0 resection via MIS versus laparotomy in IDS. The primary endpoint was overall survival (OS). Kaplan-Meier analysis and inverse probability of treatment weighting (IPTW) were used. Cases were stratified by surgical extent and within the MIS cohort by robotic assistance. Surgical outcomes (LOS, readmission rate, 30- and 90-day mortality) were also assessed. In total, 2412 patients were eligible. 624 (25.8%) underwent R0 resection via MIS. Over the study period, the MIS utilization rate increased from 12% to 36%. There was no significant difference in OS between the MIS and open cohorts (51 vs. 46 months, HR 1.1; 95% CI 0.96-1.24). 30-day and 90-day postoperative mortality rates were higher in the open group (1.6% vs. 0.8%, = 0.006) and (1.9% vs. 3.5%, = 0.003), respectively. Patients in the MIS group were less likely to undergo extensive surgery (41% vs. 53%, < 0.001). When stratified by surgical extent, no significant difference in OS was observed between MIS and laparotomy (49 vs. 44 months in the extensive surgery group and 53 vs. 50 months in the non-extensive surgery group). Within the MIS cohort, 49% of cases were performed robotically. OS did not differ significantly between robotic and conventional laparoscopic cases (52 vs. 50 months). From 2010 to 2019, there was an increase in the use of robot-assisted laparoscopy (from 6.2% to 25.5%), coinciding with a decline in the laparotomy rate (from 88.1% to 63.5%) ( = 0.008). R0 resection via MIS during IDS showed similar OS and decreased postoperative mortality compared to laparotomy. The increasing utilization of robotic assistance is associated with a decrease in the laparotomy rate.

摘要

传统上,晚期上皮性卵巢癌(EOC)采用初次肿瘤细胞减灭术进行治疗;然而,最近的III期试验表明,与接受初次肿瘤细胞减灭术(PDS)的患者相比,随机接受新辅助化疗后行间隔性肿瘤细胞减灭术(IDS)的患者生存结果相似。我们试图评估一组在2010年至2019年期间确诊的EOC患者,这些患者在IDS期间接受了完全细胞减灭术(R0 - 无肉眼残留病灶)。我们比较了IDS中通过微创外科手术(MIS)与开腹手术进行R0切除后的结果。主要终点是总生存期(OS)。采用Kaplan - Meier分析和治疗权重逆概率(IPTW)方法。病例按手术范围分层,在MIS队列中按机器人辅助情况分层。还评估了手术结果(住院时间、再入院率、30天和90天死亡率)。总共2412例患者符合条件。624例(25.8%)通过MIS进行了R0切除。在研究期间,MIS的使用率从12%增加到36%。MIS组和开腹手术组的OS无显著差异(51个月对46个月,风险比1.1;95%置信区间0.96 - 1.24)。开腹手术组的30天和90天术后死亡率较高(分别为1.6%对0.8%,P = 0.006)和(1.9%对3.5%,P = 0.003)。MIS组患者接受广泛手术的可能性较小(41%对53%,P < 0.001)。按手术范围分层时,MIS组和开腹手术组的OS无显著差异(广泛手术组为49个月对44个月,非广泛手术组为53个月对50个月)。在MIS队列中,49%的病例采用机器人辅助进行。机器人辅助手术和传统腹腔镜手术病例的OS无显著差异(52个月对50个月)。从2010年到2019年,机器人辅助腹腔镜手术的使用率有所增加(从6.2%增至25.5%),同时开腹手术率下降(从88.1%降至63.5%)(P = 0.008)。IDS期间通过MIS进行R0切除与开腹手术相比,显示出相似的OS且术后死亡率降低。机器人辅助使用率的增加与开腹手术率的下降相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d986/11856761/593b3307c8e4/jcm-14-01164-g001.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验